These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1235 related articles for article (PubMed ID: 6848194)

  • 21. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
    Shinoda H; Inaba M; Tsuruo T
    Cancer Res; 1989 Apr; 49(7):1722-6. PubMed ID: 2924316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM; Otter GM; Schmid FA
    Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxorubicin resistance circumvention by verapamil in B16 melanoma cells.
    Mariani M; Prosperi E; Colombo A; Supino R
    Anticancer Res; 1989; 9(1):29-32. PubMed ID: 2705752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular pharmacology of doxorubicinol alone and combined with verapamil in pancreatic cancer cell lines.
    Chang BK; Brenner DE; Gutman R
    Anticancer Res; 1989; 9(2):341-5. PubMed ID: 2751259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
    Breier A; Drobná Z; Barancík M
    Neoplasma; 1998; 45(4):248-53. PubMed ID: 9890669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of antitumor activity of vincristine by the biscoclaurine alkaloid cepharanthine.
    Kato T; Suzumura Y
    J Natl Cancer Inst; 1987 Sep; 79(3):527-32. PubMed ID: 3476792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
    Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
    Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Difference in effects of alkyl-lysophospholipids and verapamil on vincristine transport in vincristine-sensitive and -resistant human myelogenous leukemia K562.
    Tsuruo T; Saito H
    Anticancer Res; 1987; 7(1):39-43. PubMed ID: 3471174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.
    Yoshimatsu K; Yamaguchi A; Yoshino H; Koyanagi N; Kitoh K
    Cancer Res; 1997 Aug; 57(15):3208-13. PubMed ID: 9242451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation of the verapamil-induced enhancement of doxorubicin's cytotoxicity from changes in cellular accumulation or retention of doxorubicin in pancreatic cancer cell lines.
    Chang BK; Brenner DE; Gutman R
    Anticancer Res; 1989; 9(2):347-51. PubMed ID: 2751260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic instability of drug sensitivity in a human colon carcinoma cell line.
    Ferguson PJ; Cheng YC
    Cancer Res; 1989 Mar; 49(5):1148-53. PubMed ID: 2563672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of duration of exposure to S9788, cyclosporin A or verapamil on sensitivity of multidrug resistant cells to vincristine or doxorubicin.
    Pérez V; Pierré A; Léonce S; Anstett M; Atassi G
    Anticancer Res; 1993; 13(4):985-90. PubMed ID: 8352569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Apr; 42(4):1462-7. PubMed ID: 7060020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time dependence of [3H]-vincristine accumulation by L1210 mouse leukemic cells. Effect of P-glycoprotein overexpression.
    Breier A; Stefanková Z; Barancík M; Tribulová N
    Gen Physiol Biophys; 1994 Aug; 13(4):287-98. PubMed ID: 7890145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the modulation of antiblastics cytotoxicity by verapamil and dipyridamole in a human colon carcinoma cell line.
    Berti E; Carrara M; Ragazzi E; D'Ancona S; Berti T
    Int J Oncol; 1999 Jul; 15(1):155-60. PubMed ID: 10375609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin, vincristine, and actinomycin-D, but not teniposide, require long-lasting uninterrupted verapamil pressure to overcome drug resistance in multidrug-resistant cells.
    Toffoli G; Tumiotto L; Gigante M; Perin T; Biscontin G; Boiocchi M
    Cancer Detect Prev; 1993; 17(3):425-32. PubMed ID: 8402730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overcoming of vincristine resistance in HL-60 human promyelocytic leukemia cell line by dipyridamole.
    Hirose M; Takeda E; Kuroda Y
    Tokushima J Exp Med; 1993 Jun; 40(1-2):27-33. PubMed ID: 8211977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine and L-phenylalanine mustard.
    Horton JK; Houghton PJ; Houghton JA
    Cancer Res; 1987 Dec; 47(23):6288-93. PubMed ID: 2890432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
    Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
    Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of verapamil on in vitro cytotoxicity of adriamycin and vinblastine in human tumor cells.
    Goodman GE; Yen YP; Cox TC; Crowley J
    Cancer Res; 1987 May; 47(9):2295-304. PubMed ID: 3567923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.